Med1 plays a critical role in the development of tamoxifen resistance.

Carcinogenesis
Arumugam NagalingamDipali Sharma

Abstract

Understanding the molecular pathways that contribute to the development of tamoxifen resistance is a critical research priority as acquired tamoxifen resistance is the principal cause of poor prognosis and death of patients with originally good prognosis hormone-responsive breast tumors. In this report, we provide evidence that Med1, an important subunit of mediator coactivator complex, is spontaneously upregulated during acquired tamoxifen-resistance development potentiating agonist activities of tamoxifen. Phosphorylated Med1 and estrogen receptor (ER) are abundant in tamoxifen-resistant breast cancer cells due to persistent activation of extracellular signal-regulated kinases. Mechanistically, phosphorylated Med1 exhibits nuclear accumulation, increased interaction with ER and higher tamoxifen-induced recruitment to ER-responsive promoters, which is abrogated by inhibition of Med1 phosphorylation. Stable knockdown of Med1 in tamoxifen-resistant cells not only reverses tamoxifen resistance in vitro but also in vivo. Finally, higher expression levels of Med1 in the tumor significantly correlated with tamoxifen resistance in ER-positive breast cancer patients on adjuvant tamoxifen monotherapy. In silico analysis of breast cance...Continue Reading

References

Jun 1, 1994·Molecular Endocrinology·P AugereauH Rochefort
Nov 11, 1993·International Journal of Cancer. Journal International Du Cancer·X F HuJ R Zalcberg
Apr 16, 1998·American Journal of Clinical Oncology·A U Buzdar
Mar 5, 1999·Breast Cancer Research and Treatment·M J EllisA Harris
Jul 13, 2000·Molecular and Cellular Biology·Y RenJ D Fondell
Jul 14, 2001·Nucleic Acids Research·C M Klinge
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yun Kyoung KangRobert G Roeder
May 30, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dipali Sharma, Joseph D Fondell
Nov 6, 2002·Biological Research·Stephen M Hart
Dec 11, 2002·Molecular Cancer·Xiuhua GaoZafar Nawaz
Dec 12, 2002·Steroids·Deborah A Lannigan
May 9, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hirotaka Iwase
Sep 18, 2003·Journal of Neuroscience Research·Yun XuMichael M Wang
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rachel SchiffC Kent Osborne
Jun 23, 2004·Critical Reviews in Oncology/hematology·Nadine PlatetMarcel Garcia
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leigh C MurphyPeter Watson
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa RydénUNKNOWN South-East Swedish Breast Cancer Group
Feb 1, 2005·FEBS Letters·Joan Weliky ConawayRonald C Conaway
May 18, 2005·Trends in Biochemical Sciences·James Z Chadick, Francisco J Asturias
Aug 10, 2005·The Journal of Pathology·Tove KirkegaardJohn M S Bartlett
Jan 6, 2006·Molecular Interventions·Julie M Hall, Donald P McDonnell
Apr 1, 2006·The Journal of Biological Chemistry·T S UdayakumarJoseph D Fondell
Apr 25, 2006·Reviews of Physiology, Biochemistry and Pharmacology·M Belakavadi, J D Fondell
Nov 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Melanie StumpfTilman Borggrefe
Sep 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V AdamoN Caristi
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jie JiangSimak Ali
Nov 27, 2007·Journal of Clinical Pathology·R A Walker

❮ Previous
Next ❯

Citations

Apr 25, 2013·Nature Reviews. Cancer·Megan J BywaterRoss D Hannan
Jul 10, 2013·Nature Reviews. Clinical Oncology·Emily CrowleyAlberto Bardelli
May 1, 2013·Biochimica Et Biophysica Acta·William JacotPierre-Jean Lamy
Nov 17, 2015·Expert Review of Molecular Diagnostics·Adrien SaliouJean-Yves Pierga
Oct 4, 2013·Critical Reviews in Biochemistry and Molecular Biology·Zachary C PossDylan J Taatjes
Jan 19, 2016·Molecular Oncology·Leticia De Mattos-Arruda, Carlos Caldas
Nov 16, 2012·Proteomics·Milagros J Tenga, Iulia M Lazar
Nov 22, 2015·Nucleic Acids Research·Malini NagulapalliJitendra K Thakur
Dec 6, 2017·Endocrine-related Cancer·Marijn A VermeulenCathy B Moelans
May 16, 2019·Journal of Zhejiang University. Science. B·Marissa Leonard, Xiaoting Zhang
Jun 20, 2020·Science·Isaac A KleinRichard A Young
Mar 1, 2019·International Journal of Molecular Sciences·Ángel Salmerón-HernándezElizabeth Langley
Apr 16, 2014·Cancer Research·Arumugam NagalingamNeeraj K Saxena
Jan 9, 2021·Cancer Cell·Ann BoijaRichard A Young
Jan 30, 2021·The Biochemical Journal·Martin StortzValeria Levi
Nov 22, 2017·Steroids·Hannah Weber, Michael J Garabedian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.